Integrated analysis of
Aged
Aged, 80 and over
Cystectomy
Female
Fluorodeoxyglucose F18
/ pharmacology
Humans
Lymph Nodes
/ diagnostic imaging
Lymphatic Metastasis
Male
Middle Aged
Neoplasm Staging
Pelvis
Positron Emission Tomography Computed Tomography
/ methods
Preoperative Period
Radiopharmaceuticals
/ pharmacology
Urinary Bladder Neoplasms
/ diagnosis
Lymph nodes
Neoplasm staging
Positron emission tomography computed tomography
Urinary bladder neoplasms
Journal
European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
05
11
2018
accepted:
05
12
2018
revised:
26
11
2018
pubmed:
23
1
2019
medline:
19
11
2019
entrez:
23
1
2019
Statut:
ppublish
Résumé
Preoperative From May 2015 to May 2017, we prospectively included patients with urothelial bladder cancer who underwent radical cystectomy with extended pelvic LN dissection. All patients underwent preoperative In total, 1012 LNs were identified in 61 patients with clinically localized invasive bladder cancer who underwent radical cystectomy and extended pelvic LN dissection. Loco-regional involvement of 24 LN areas was confirmed in 17 patients. In per area analysis, diagnostic accuracy of PET/CT and CT alone were respectively 84% and 78% (p = 0.039). On patient-based analysis, combined PET/CT correctly classified pelvic LN status in 5/61 (+ 8%) additional patients using optimal thresholds compared to CT alone, with accuracies of 82% and 74%, respectively (p = 0.13). Combining SUV • Combining metabolical and morphological features using
Identifiants
pubmed: 30666449
doi: 10.1007/s00330-018-5959-0
pii: 10.1007/s00330-018-5959-0
doi:
Substances chimiques
Radiopharmaceuticals
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4286-4293Références
Mod Pathol. 2001 Jun;14(6):629-32
pubmed: 11406667
Eur Urol. 2010 Apr;57(4):641-7
pubmed: 19477579
J Clin Oncol. 2009 Sep 10;27(26):4314-20
pubmed: 19652070
J Clin Oncol. 2010 Sep 1;28(25):3973-8
pubmed: 20679618
Eur Urol. 2012 May;61(5):1039-47
pubmed: 22381169
Ann Nucl Med. 2012 Aug;26(7):571-7
pubmed: 22763630
Int J Urol. 2013 Aug;20(8):788-96
pubmed: 23279605
BJU Int. 2013 Oct;112(6):729-34
pubmed: 23790129
BJU Int. 2014 Sep;114(3):389-95
pubmed: 24341486
Eur J Surg Oncol. 2014 Dec;40(12):1724-30
pubmed: 25242381
Ann Surg Oncol. 2015 Sep;22(9):3150-6
pubmed: 25634779
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
BMC Urol. 2015 Aug 21;15:87
pubmed: 26294219
World J Urol. 2016 Sep;34(9):1229-37
pubmed: 26847182
Eur Radiol. 2016 Dec;26(12):4345-4353
pubmed: 27011373
Int Braz J Urol. 2016 Mar-Apr;42(2):234-41
pubmed: 27256176
Lancet. 2016 Dec 3;388(10061):2796-2810
pubmed: 27345655
Eur Urol. 2017 Jan;71(1):96-108
pubmed: 27370177
Eur Urol. 2017 Mar;71(3):462-475
pubmed: 27375033
Eur Radiol. 2017 May;27(5):2146-2152
pubmed: 27553924
Clin Genitourin Cancer. 2017 Jun;15(3):e387-e395
pubmed: 27601364
Eur Radiol. 2017 Sep;27(9):3752-3758
pubmed: 28168374
Eur Radiol. 2017 Sep;27(9):3759-3766
pubmed: 28181054
Curr Opin Oncol. 2017 Mar 16;:null
pubmed: 28306559
Nat Rev Dis Primers. 2017 Apr 13;3:17022
pubmed: 28406148
Eur Urol. 2017 Sep;72(3):411-423
pubmed: 28645491
Eur Urol Focus. 2019 Jan;5(1):90-96
pubmed: 28753817